Why the Nufarm Limited (ASX:NUF) share price is surging higher

Our market has sunk firmly into the red but at least shareholders in Nufarm Limited (ASX:NUF) have something to smile about as the stock is among the best performers on the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Our market has sunk firmly into the red but at least shareholders in Nufarm Limited (ASX: NUF) have something to smile about as the stock was among the best performers on the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index yesterday.

The stock jumped 3.6% to a near four-week high of $7.16 in the final hour of trade. It's the fifth best performing stock on the ASX 200 after Ausdrill Limited (ASX: ASL), Sims Metal Management Ltd (SGM), Evolution Mining Ltd (ASX: EVN) and Speedcast International Ltd (ASX: SDA).

Nufarm's strong performance is a welcome change from its big August sell-off on the back of the Monsanto lawsuit over the use of Glyphosate. Monsanto was ordered to pay US$289 million by a US court after a cancer sufferer sued the company for causing his illness by using the chemical in its weed killer product.

Nufarm uses a similar active ingredient in its crop protection products and a Brazilian court had ordered the suspension of the use of Glyphosate.

But Nufarm announced today that the Brazilian court's decision has been overturned. The suspension was supposed to have come into effect this week.

Deutsche Bank estimates that Glyphosate-based products account for 23% of Nufarm's total revenue and 15% of earnings before interest, tax, depreciation and amortisation (EBITDA). The broker warned that losing all these sales will shave 15% off the company's earnings per share.

The regulatory pressure over Glyphosate may not be over yet though as the debate over whether the chemical is carcinogenic rages on.

However, even if regulatory pressure intensifies, I don't believe the use of Glyphosate will be outlawed. New rules may require better warning labels or the mandatory use of safety equipment. The fact is, there isn't a good substitute for the chemical when it comes to crop protection.

Furthermore, the recent approval of Nufarm's proprietary omega-3 canola by the US Agriculture Department (USDA) brings the company a big step forward in commercialising the product.

Getting the tick of approval by the USDA will pave the way for the company to gain approval from other countries, including Australia.

The new seeds represent an exciting opportunity for Nufarm with omega-3 oils currently only being able to be sourced from fish. Omega-3 canola is a more sustainable way to produce the healthy fatty acid.

The ongoing drought in parts of New South Wales and Queensland, and the controversy over Glyphosate will hang over Nufarm's share price over the near-term, but investors with a longer-term view should use any share price weakness as a buying opportunity.

Looking for other attractive large cap buys? The experts at the Motley Fool have picked three of their best blue-chip stock ideas for FY19.

Follow the free link below to find out what these stocks are.

Motley Fool contributor Brendon Lau owns shares of Nufarm Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »